Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare type of blood cancer that starts in your plasma cells. Your plasma cells are a type of white blood cell inside your bone marrow, the ...

(1:33) The R-ISS for stratifying risk in multiple myeloma patients is outdated, and the risk of death or disease progression is heterogeneous among patients in the R-ISS II group. The newer ...

SkylineDx’s SKY92 test with fluorescence in situ hybridisation testing led to more accurate identification of high-risk myelomas.

SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for oncology, and inflammatory and infectious diseases, announces the publication of ...

Clin Lymphoma Myeloma. 2009;9(6):436-442. Calculations for the statistical analysis were performed using the STATISTICA data analysis software system, version 8.0. The Kaplan-Meier method was used ...

SKY92 measures the activity of 92 genes in the malignant myeloma plasma cells to ... changes in cells per the Second Revised International Staging System (R2-ISS) for risk quantification.

Footnotes: Zhou et al. Combining SKY92 gene expression profiling and FISH (according to R2-ISS) defines ultra-high-risk Multiple Myeloma. Combining SKY92 gene expression profiling and FISH ...